Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System

BACKGROUND: A licensed vaccine against hepatitis C virus (HCV) has not become available to date. The stability and antigenicity of a targeted synthesized recombinant fusion protein consisting of a truncated core and NS3 (rC/N) of HCV had been predicted. Although safe antigens, recombinant proteins a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hekmat, Soheila, Sadat, Seyed Mehdi, Aslani, Mohammad Mehdi, Mahdavi, Mehdi, Bolhassani, Azam, Halvaee, Fateme Asgar, Ghahari, Seyed Mohammad Mahdi, Aghasadeghi, Mohammad Reza, Siadat, Seyed Davar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute 2019
Materias:
Full Length
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462289/
https://www.ncbi.nlm.nih.gov/pubmed/30278608
http://dx.doi.org/10.29252/.23.4.235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462289/
https://www.ncbi.nlm.nih.gov/pubmed/30278608
http://dx.doi.org/10.29252/.23.4.235

Ejemplares similares